metformin has been researched along with Prostatic Diseases in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Prostatic Diseases: Pathological processes involving the PROSTATE or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 1 |
| Olumi, AF | 1 |
1 other study available for metformin and Prostatic Diseases
| Article | Year |
|---|---|
Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease?
Topics: Animals; Cell Proliferation; DNA Methylation; Epigenesis, Genetic; Humans; Male; Metformin; Prostate | 2018 |